NU

Nureca LtdNSE NURECA Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.077

Micro

Exchange

XNSE - National Stock Exchange Of India

NURECA.NS Stock Analysis

NU

Uncovered

Nureca Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-1/100

Low score

Market cap $B

0.077

Dividend yield

0.36 %

Shares outstanding

10 B

Nureca Ltd. design and manufactures health monitoring devices. The company is headquartered in Mumbai, Maharashtra and currently employs 102 full-time employees. The company went IPO on 2021-02-25. The main products/services that the Company manufactures include chronic disease products, orthopedic products, mother and child products, nutrition supplements, lifestyle products, and connected devices. Its chronic disease products include nebulizers, BP monitors, finger pulse oximeters, glucose meters and thermometers. Its orthopedic products include wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers. Its mother and babycare products include baby feeding, carry cots, baby skincare, nebulizers and bottle warmers and steamers. Its nutrition supplements include supplements and weight management products. Its lifestyle products include humidifiers and steamers, personal scales, massagers, fitness tracking, and dental and personal care. The firm's products are offered through its brands, such as Dr Trust, Dr Physio, and Trumom.

View Section: Eyestock Rating